13C Isotope-Labeled Metabolomes Allowing for Improved Compound Annotation and Relative Quantification in Liquid Chromatography-Mass Spectrometry-based Metabolomic Research
Citations Over TimeTop 10% of 2009 papers
Abstract
Metabolomics is rapidly becoming an integral part of many life science studies ranging from disease diagnostics to systems biology. However, a number of problems such as the discrimination of biological from non-biological signals, efficient compound annotation, and reliable quantification are still not satisfactorily solved in untargeted LC-MS-based metabolomics research. Extending our previous work on direct infusion-based metabolomics, we here describe a (13)C isotope labeling strategy in combination with an Ultra Performance Liquid Chromatography Fourier Transform Ion Cyclotron Resonance Mass Spectrometry-based approach (UPLC-FTICR MS) which provides a technological platform offering solutions to a number of the above-mentioned problems. We further demonstrate that the use of a fully labeled metabolome is not only beneficial for high end mass spectrometers, such as that used in this study but also provides a considerable improvement to every other mass spectrometry-based metabolomic platform.
Related Papers
- → Identification of bioactive metabolites using activity metabolomics(2019)995 cited
- → A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice(2013)355 cited
- → Microbial metabolomics: Toward a platform with full metabolome coverage(2007)206 cited
- → The use of metabolomics for the discovery of new biomarkers of effect(2007)204 cited
- → Metabolomics: Metabolome measurement in human plasma(2006)